McKenzie MediCare Circulation Support Complex
Natural health product licensed in Canada
- Other names
- McKenzie MediCare Circulation Help Complex
- Licence holder
- Canada Mckenzie Nutrition
- NPN or DIN-HM
- 80102044
- Status
- Active licence
- Licence date
- 22 June 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Sélénium: up to 60 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ginkgo biloba Source : Feuille Potency : 20 % Flavonoid glycosides | Not specified | Not calculated |
| Sélénium Source : Aspartate de sélénium | 15 mcg | 60 µg |
| Panax quinquefolius Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 0.15 g | 30 mg | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 1.5 g Potency : 5 % Terpene lactones | 30 mg | Not calculated |
| Dendrobium nobile Source : Tige Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 0.15 g | 30 mg | Not calculated |
| Moringa oleifera Source : Graine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 0.25 g | 50 mg | Not calculated |
| Panax notoginseng Source : Rhizome | 300 mg | Not calculated |
| Panax notoginseng Source : Racine | 300 mg | Not calculated |
Non-medicinal ingredients
Lutéine, Cellulose microcristalline, Stéarate de magnésium, Concentré de jus de myrtille, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels. Used in Herbal Medicine to help relieve restlessness and/or nervousness. Used in Herbal Medicine as an adaptogen to help maintain a healthy immune system. Helps to enhance cognitive function and memory in adults. Helps to support peripheral circulation. A factor in the maintenance of good health and normal growth and development. Antioxidants for good health. Source of antioxidants that help fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Helps to maintain normal function of the thyroid gland.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. If you are taking prescription medications, consult a health care practitioner prior to use. If you are taking blood thinners or digoxin, consult a health care practitioner prior to use. If you have diabetes, consult a health care practitioner prior to use. if you are taking medications for diabetes, high blood pressure or seizures, consult a health care practitioner prior to use. If you have an autoimmune disorder, consult a health care practitioner prior to use.
- Contre-indications
If you are pregnant or breastfeeding, do not use this product. Do not use this product if you are taking health products that affect blood coagulation as this may increase the risk of spontaneous bleeding.
Source
Official Health Canada record, licence 80102044
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.